110 related articles for article (PubMed ID: 17034764)
1. Identification of two biologically crucial hydroxyl groups of (-)-epigallocatechin gallate in osteoclast culture.
Nakagawa H; Hasumi K; Takami M; Aida-Hyugaji S; Woo JT; Nagai K; Ishikawa T; Wachi M
Biochem Pharmacol; 2007 Jan; 73(1):34-43. PubMed ID: 17034764
[TBL] [Abstract][Full Text] [Related]
2. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate.
Nakagawa H; Hasumi K; Woo JT; Nagai K; Wachi M
Carcinogenesis; 2004 Sep; 25(9):1567-74. PubMed ID: 15090467
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the biological activities of methylated derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) and their cell surface binding activities.
Yano S; Fujimura Y; Umeda D; Miyase T; Yamada K; Tachibana H
J Agric Food Chem; 2007 Aug; 55(17):7144-8. PubMed ID: 17661493
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a novel O-methyltransferase from Camellia sinensis and synthesis of o-methylated EGCG and evaluation of their bioactivity.
Kirita M; Honma D; Tanaka Y; Usui S; Shoji T; Sami M; Yokota T; Tagashira M; Muranaka A; Uchiyama M; Kanda T; Maeda-Yamamoto M
J Agric Food Chem; 2010 Jun; 58(12):7196-201. PubMed ID: 20476742
[TBL] [Abstract][Full Text] [Related]
5. Chemiluminescence analysis of the prooxidant and antioxidant effects of epigallocatechin-3-gallate.
Tian B; Sun Z; Xu Z; Hua Y
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():153-7. PubMed ID: 17392095
[TBL] [Abstract][Full Text] [Related]
6. Hibernation, reversible cell growth inhibition by epigallocatechin-3-O-gallate.
Matsumura K; Kim JY; Tsutsumi S; Hyon SH
J Biotechnol; 2007 Jan; 127(4):758-64. PubMed ID: 16996160
[TBL] [Abstract][Full Text] [Related]
7. Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry.
Mizooku Y; Yoshikawa M; Tsuneyoshi T; Arakawa R
Rapid Commun Mass Spectrom; 2003; 17(16):1915-8. PubMed ID: 12876693
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor activities of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo.
Matsumura K; Kaihatsu K; Mori S; Cho HH; Kato N; Hyon SH
Biochem Biophys Res Commun; 2008 Dec; 377(4):1118-22. PubMed ID: 18983978
[TBL] [Abstract][Full Text] [Related]
9. Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (-)-epigallocatechin gallate.
Dorchies OM; Wagner S; Buetler TM; Ruegg UT
Biofactors; 2009; 35(3):279-94. PubMed ID: 19322813
[TBL] [Abstract][Full Text] [Related]
10. Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity.
Furuta T; Hirooka Y; Abe A; Sugata Y; Ueda M; Murakami K; Suzuki T; Tanaka K; Kan T
Bioorg Med Chem Lett; 2007 Jun; 17(11):3095-8. PubMed ID: 17420124
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB.
Moon YH; Lee JH; Ahn JS; Nam SH; Oh DK; Park DH; Chung HJ; Kang S; Day DF; Kim D
J Agric Food Chem; 2006 Feb; 54(4):1230-7. PubMed ID: 16478241
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
Lin SK; Chang HH; Chen YJ; Wang CC; Galson DL; Hong CY; Kok SH
Arthritis Rheum; 2008 Oct; 58(10):3145-56. PubMed ID: 18821707
[TBL] [Abstract][Full Text] [Related]
13. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
Morinobu A; Biao W; Tanaka S; Horiuchi M; Jun L; Tsuji G; Sakai Y; Kurosaka M; Kumagai S
Arthritis Rheum; 2008 Jul; 58(7):2012-8. PubMed ID: 18576345
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
16. Structure and intramolecular flexibility of beta-cyclodextrin complex with (-)-epigallocatechin gallate in aqueous solvent.
Ishizu T; Hirata C; Yamamoto H; Harano K
Magn Reson Chem; 2006 Aug; 44(8):776-83. PubMed ID: 16705621
[TBL] [Abstract][Full Text] [Related]
17. Systematic characterization of the covalent interactions between (-)-epigallocatechin gallate and peptides under physiological conditions by mass spectrometry.
Cao D; Zhang Y; Zhang H; Zhong L; Qian X
Rapid Commun Mass Spectrom; 2009 Apr; 23(8):1147-57. PubMed ID: 19280611
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 A reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead.
Skrzypczak-Jankun E; Zhou K; Jankun J
Int J Mol Med; 2003 Oct; 12(4):415-20. PubMed ID: 12964012
[TBL] [Abstract][Full Text] [Related]
19. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death.
Nakagawa H; Wachi M; Woo JT; Kato M; Kasai S; Takahashi F; Lee IS; Nagai K
Biochem Biophys Res Commun; 2002 Mar; 292(1):94-101. PubMed ID: 11890677
[TBL] [Abstract][Full Text] [Related]
20. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP
J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
